Clinical Trials
5
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis
- Conditions
- Osteo Arthritis Knee
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- Aptissen SA
- Target Recruit Count
- 51
- Registration Number
- NCT05829850
- Locations
- 🇵🇱
Carolina Medical Center, Warszawa, Poland
🇵🇱SPORTO oddzial na ulicy Miedzianej, Łódź, Poland
🇵🇱SPORTO oddzial na ulicy Książka (2nd site location), Łódź, Poland
An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis
- Conditions
- Osteoarthritis, Knee
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2023-04-26
- Lead Sponsor
- Aptissen SA
- Target Recruit Count
- 82
- Registration Number
- NCT05829798
- Locations
- 🇵🇱
Klinika Chirurgii Kolana Dr Słynarskiego, Warszawa, Poland
🇵🇱NZOZ Carolina Medical Center - Sport Medica S.A, Warszawa, Poland
🇵🇱SPORTO Spółka z o.o., Łódź, Poland
6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis
- Conditions
- Osteoarthritis, Hip
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Aptissen SA
- Target Recruit Count
- 70
- Registration Number
- NCT05829733
- Locations
- 🇫🇷
Service de Rhumatologie, Hôpital Nord Franche-Comté, Belfort, France
🇫🇷Service de chirurgie orthopédique et traumatologie Centre Hospitalier de Dunkerque CHD, Dunkerque, France
🇫🇷Service d'Orthopédie II (Membre Inférieur, Chirurgie du Sport et Chirurgie Septique) Hôpital Salengro, CHRU de Lille, Lille, France
EVI-01-IT Safety Study
- Conditions
- Knee Osteoarthritis
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Aptissen SA
- Target Recruit Count
- 24
- Registration Number
- NCT05422976
- Locations
- 🇮🇹
IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee
- Conditions
- OsteoarthritisOsteoarthritis, Knee
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Aptissen SA
- Target Recruit Count
- 120
- Registration Number
- NCT05337540
- Locations
- 🇧🇷
A2Z Clinical, Valinhos, São Paulo, Brazil
🇧🇷Ortocity, São Paulo, Brazil